These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3373720)

  • 1. Clinical significance of Vanghan Williams classification for treatment of ventricular tachycardia: study of class IA and IB antiarrhythmic agents.
    Kasanuki H; Ohnishi S; Tanaka E; Hirosawa K
    Jpn Circ J; 1988 Mar; 52(3):280-8. PubMed ID: 3373720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
    Tanabe T; Yoshikawa H; Furuya H; Goto Y
    Jpn Circ J; 1988 Mar; 52(3):298-305. PubMed ID: 3373722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T; Costi P; Dubuc M; Shenasa M
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
    Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
    Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and mechanisms of prevention and termination of verapamil-sensitive sustained ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hosoda S
    Am J Cardiol; 1989 Dec; 64(20):46J-49J. PubMed ID: 2480708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of class Ia/Ib versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associated with coronary artery disease.
    Khalighi K; Peters RW; Feliciano Z; Shorofsky SR; Gold MR
    Am J Cardiol; 1997 Sep; 80(5):591-4. PubMed ID: 9294987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y; Chinushi M; Naitoh N; Shibata A
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chronic recurrent idiopathic ventricular tachycardia.
    Sakurai M; Nishiono T; Yoshida I; Kato N; Yasuda H
    Jpn Circ J; 1988 Mar; 52(3):272-9. PubMed ID: 3373719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN; Saksena S
    Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L; Kadish A; Morady F
    Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proarrhythmic effects of antiarrhythmic drugs assessed by electrophysiologic study in recurrent sustained ventricular tachycardia.
    Chinushi M; Aizawa Y; Miyajima S; Funazaki T; Tamura M; Shibata A
    Jpn Circ J; 1991 Feb; 55(2):133-41. PubMed ID: 2020083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.